INITIAL PHASE 1 RESULTS OF THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY HU5F9-G4 IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS. Author(s):. Paresh Vyas.
確定! 回上一頁